Skip to main content
Premium Trial:

Request an Annual Quote

Gary Guthart

Illumina has named Gary Guthart to its board of directors, effective Dec. 1, 2017. Guthart is president and CEO of Intuitive Surgical, which makes robots to assist with minimally invasive surgery. He has held a variety of roles at Intuitive Surgical since 1996 and previously developed foundational technology for computer-enhanced surgery at SRI International, which was formerly the Stanford Research Institute. He also served on the board of directors at Affymetrix from 2009 until it was acquired by Thermo Fisher Scientific in 2016.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.